Levetiracetam Noridem Enterprises Limited

Levetiracetam, the active ingredient in Levetiracetam Noridem Enterprises Limited, is an antiepileptic presented as an injection for intravenous use. It treats partial seizures, generalized tonic‑clonic seizures and myoclonic seizures in patients who require rapid seizure control.

GNH USA supplies Levetiracetam Noridem Enterprises Limited as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Levetiracetam is an antiepileptic medication used to manage various seizure types. - Partial seizures: reduces the frequency and severity of focal onset seizures. - Generalized tonic‑clonic seizures: helps control convulsive episodes across the brain. - Myoclonic seizures: diminishes sudden muscle jerks associated with this seizure type.

Levetiracetam may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects: - Drowsiness: mild to moderate sedation. - Dizziness: sensation of light‑headedness. - Headache: transient cranial discomfort. - Fatigue: reduced energy levels. - Irritability: mood changes or agitation. - Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or anaphylaxis. - Mood disorders: depression or suicidal thoughts. - Hematologic abnormalities: low blood cell counts. - Hepatic dysfunction: elevated liver enzymes. - Severe skin reactions: Stevens‑Johnson syndrome. - Respiratory depression: difficulty breathing (rare).

Before using Levetiracetam injection, consider the following safety measures. - Renal impairment: dose may need adjustment in reduced kidney function. - Hepatic disease: monitor liver function tests regularly. - Pregnancy: category C; weigh benefits against potential risks. - Breastfeeding: assess infant exposure and benefits. - Concomitant CNS depressants: may enhance sedation. - Storage: Store at 2‑8°C: keep refrigerated, protect from light, do not freeze or shake.

Levetiracetam can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: can lower levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase risk of central nervous system side effects. - Fluoroquinolone antibiotics: potential for heightened neurotoxicity. - Opioids: additive sedation or respiratory depression. - Alcohol: may exacerbate dizziness and drowsiness. - Other antiepileptics: monitor for cumulative adverse effects.